The consequences of prostate cancer metastasis remain severe, with huge impact on the
mortality and overall quality of life of affected patients. Despite the convoluted interplay and …

Prostate cancer is more common in men over the age of 65 years. There are 15% cases with
positive family history of prostate cancer Worldwide. Prostate cancer is the second leading …

BACKGROUND There is few data on what constitutes the distribution of metastatic sites in
prostate cancer (PCa). The aim of our study was to systematically describe the most …

Background Limited data exist on the impact of the site of metastases on survival in patients
with stage IV prostate cancer (PCa). Objective To investigate the role of metastatic …

Drug delivery vehicles based on magnetic nanoparticles present a promising strategy for
cancer treatment, due to controlled targeted treatment, high loading efficiency, and biosafety …

More than 40% of men with intermediate-risk or high-risk prostate cancer will experience a
biochemical recurrence after radical prostatectomy. Clinical guidelines for the management …

The introduction of prostate-specific membrane antigen (PSMA) in clinical practice has
revolutionized evaluation of biochemical recurrence of prostate cancer after curative-intent …

BACKGROUND Although enumeration of circulating tumor cells (CTCs) has shown some
clinical value, the pool of CTCs contains a mixture of cells that contains additional …

Relapsing level of prostate-specific antigen (PSA) after initial curative-intent local therapy for
organ-confined prostate cancer is often the first sign of recurrence. However, PSA level …

Abstract Background 68Ga-PSMA PET/CT has an important role in assessment of prostate
cancer patients with biochemical recurrence and is evolving in staging high-and …